Previous works on controlling the major components of the metabolic syndrome (MS), have reported significant results on reducing overall cardiometabolic risk although it usually proves insufficient in clinical practice. Objective: to describe the scope of therapeutic goals in patients with MS seen at the family medicine outpatient clinic at an IPS in Bogotá DC. Methods: a descriptive retrospective study was performed; MS patients older than 20 were identified in electronic medical records from May 1 to October 31 2008; an 18-month follow-up was conducted. Results: 79 patients were eligible, predominantly females (64.5%); 69.6% belonged to the mature adult group;. mean age was 54.5 years (SD 9.3); 84.8% (n 67) were in the medium risk group and 15.2% (n 12) in the high risk group. At first follow-up, 64.5% and 58.2% met the targeted blood pressure and serum glucose goals as well as the cholesterol goals, LDL, non-HDL-C and HDL-C in 54.4%, 32.9% and 11.3%. Only 30% (n 24) attended a second follow-up visit and met blood pressure and serum glucose goals in 66.6% and 41.6%, and LDL-C, non-HDL-C and HDL-C goals in 45.8%, 45.8% and 4.1%. Waist circumference measurement goals were not met. Conclusions: goal achie­ vement was high compared to other available reports, although this data is not representative for it corresponds to only 30.7% of the initial records. Further studies are required to determine the real goal scope enabling effective intervention policies to be implemented.